ECHA Opens Second Public Consultation On Chromium (VI) Restriction Impacting EU Manufacturers

Dr Steven Brennan
Dr Steven Brennan
3 min readAI-drafted, expert reviewed
Bath tap

Key takeaway

What This Development Means

ECHA’s proposed Chromium (VI) restriction seeks to streamline regulatory enforcement while addressing health and environmental concerns. With broad implications across industrial sectors, the upcoming consultation presents a key opportunity for stakeholders to shape policy outcomes and prepare for compliance.

What is the purpose of the Chromium (VI) restriction consultation?

The consultation allows stakeholders to comment on ECHA’s proposal to regulate Chromium (VI) substances under Annex XVII. The goal is to enhance protection from carcinogenic exposures and simplify compliance across the EU by replacing the slower authorisation route.

Which industries are most affected by the Chromium (VI) restriction proposal?

Industries including aerospace, automotive, surface treatment, electronics, and medical device manufacturing are significantly affected. Any sector using chromium-based electroplating, primers, or anti-corrosion coatings should assess its risk profile and prepare for the proposed limits.

Source basis: https://echa.europa.eu/restrictions-under-consideration/-/substance-rev/80128/term

The European Chemicals Agency (ECHA) has launched a six-month public consultation (18 June–18 December 2025) on a proposed restriction of certain Chromium (VI) substances under REACH Annex XVII. This marks a pivotal shift from the existing authorisation regime and affects professionals throughout the manufacturing value chain, from aerospace and automotive to coatings and electronics.

The restriction targets widely used but hazardous compounds—like chromium trioxide and various chromates and dichromates—known for their high carcinogenic potential. The proposal, if enacted, will demand new operational and monitoring standards, with stakeholders urged to respond by 18 September 2025 for early consideration.

Background: Why Chromium (VI) Is Under Scrutiny

Chromium (VI) substances are recognised carcinogens linked to serious health risks through inhalation and environmental exposure. Despite existing authorisation controls, inconsistent application across Member States and significant processing delays have prompted ECHA to recommend a more enforceable, harmonised approach via restriction.

Currently used across sectors for corrosion protection, electroplating, and metal finishing, these compounds include chromium trioxide, sodium dichromate, and potassium chromate. ECHA’s concern also extends to potential regrettable substitution with similar toxic substances such as barium chromate.

Restriction Options And Compliance Thresholds

Two core regulatory options are proposed:

  • Option A permits continued use if site emissions remain below 2.5 kg/year to air and 15 kg/year to water, with occupational exposure limits at 5 μg/m³ or 1 μg/m³ (8-hour TWA), depending on the use category.
  • Option B imposes stricter limits—0.25 kg/year (air), 1.5 kg/year (water), and workplace exposure caps as low as 0.5 μg/m³.

The restriction would apply to substances ≥0.01% w/w in mixtures, covering all stoichiometries and hydration forms. A uniform 18-month transition period is proposed following adoption.

Who’s Affected And What Comes Next

Beyond manufacturers, the restriction could impact importers, downstream users, coating applicators, and the recycling sector. Companies will need to review monitoring practices, assess emissions, and potentially substitute materials—posing both cost implications and innovation opportunities.

The ECHA Committees for Risk Assessment (RAC) and Socio-Economic Analysis (SEAC) will finalise their opinions by mid-2026. Industry input during consultation will be critical to shaping the final regulatory design.

Get weekly regulatory updates:

Related Articles

Join 3,500+ professionals staying ahead

Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.

Free forever. Unsubscribe anytime.

Read by professionals at

Boeing
AstraZeneca
Siemens
PepsiCo
SpaceX